FLU OIA^®

The Problem -
Influenza A and B

• Influenza is the 6th leading cause of death in the U.S.
• Flu vaccines are not always effective
• Studies show 60% of patients with influenza are commonly misdiagnosed as having a bacterial illness and antibiotics are given inappropriately

The Solution -
FLU OIA^®

• The only rapid test for the detection of influenza A and B with sensitivity equialent to 14-day viral culture*
• Results are available in 15 minutes, allowing the physician to make a treatment decision during an initial visit

Easy-to-Use

Simple test procedure
No additional equipment required

Multiple Specimen Types

Nasal Aspirate, Nasopharyngeal Swab,
Throat Swab, Sputum

Positive FLU OIA Test Results May:

• Indicate the presence of Influenza A and/or B antigen
• Prevent further unnecessary diagnostic work-ups
• Allow the physician to prescribe specific antiviral therapy
• Avoid unnecessary use of antibiotics
• Avert serious complications

Negative FLU OIA Test Results May:

• Indicate infection with Influenza A or B is unlikely
• Indicate the need for supportive care in absence of influenza
• Lead the physician to search for other causes

Product Accuracy:

The only rapid flu test as sensitive as
14-day viral culture.

Competitive Comparison

Clicking on this text will take you to a competitive comparison of rapid influenza diagnostic products.

Links to Additional Sources of Influenza Information:

• CDC Influenza Homepage
• CDC Influenza Weekly Update (U.S. Surveillance)
• European Influenza Surveillance
• World Health Organization Influenza Surveillance
• Influenza: A to B (learning module)
• The 1918 Influenza Pandemic
• European Scientific Working Group on Influenza
• Flu Facts

The FLU OIA test was developed through a collaboration with Biota Holdings, Ltd. of Melbourne, Australia.